Delivery Order SPE2DB24D2101-SPE2DB25FKFGL

Award Date 11/5/24
Potential Completion Date 11/6/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,346.27 firm-fixed-price delivery order is for the supply of Orencia 250 mg vials, a specialty medication. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,574.84 firm fixed-price delivery order is for the supply of 125 mg/mL Orencia syringes. The contract has a period of performance through May 21, 2024 and is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,387.58, is for the delivery of Orencia 250 mg vials, a specialty medication. It is a firm fixed-price delivery order contract with a completion date of January 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Orencia Clickject 125 mg/ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $27,136.20 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This contract award from the Defense Logistics Agency (DLA) is for the delivery of Orencia ClickJect 125 mg/ml medication to support military healthcare programs. The $17,931.22 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 18, 2025, with a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,402.97 firm-fixed-price delivery order is for the supply of Orencia 250 mg vials, with a completion date of November 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Orencia 250 mg vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). It is a firm-fixed price delivery order with a ceiling value of $4,069.44 and a completion date of June 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, supplies a wide range of medications and medical supplies to various government agencies, particularly the Department of Defense...
This federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp covers the delivery of Orencia 125 mg/mL syringes. The $7,953.78 Firm Fixed Price Delivery Order does not have a set-aside designation, indicating open competition. The contract has a period of performance through November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Orencia ClickJect 125 mg/mL pharmaceutical products to the Defense Logistics Agency (DLA). The $27,920.24 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on November 16, 2023, with a completion date of November 17, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Orencia 125 mg/ml syringes. The $47,802.52 firm fixed-price delivery order contract has a period of performance through November 6, 2024. No set-aside designation was used for this award. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKFGL
    Delivery Order

This contract award is for the delivery of Orencia 250 mg vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $12,828.93, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a period of performance through November 6, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract does not have a set-aside designation, indicating open competition. No subcontractors are mentioned in the information provided.

Generated 5/20/25, 2:25 PM